Diagnosis of Complete Response to Neoadjuvant Chemotherapy Using Diagnostic Imaging in Primary Breast Cancer Patients
- 12 September 2005
- journal article
- research article
- Published by Hindawi Limited in The Breast Journal
- Vol. 11 (5) , 311-316
Abstract
Advances in the therapeutic agents used for neoadjuvant chemotherapy (NAC) have recently achieved higher response rates and induced a greater number of pathologic complete responses (pCR) than ever before. The aim of this study is the diagnosis of pCR after NAC by diagnostic imaging of clinical complete response (cCR) patients. This study included 35 breast cancer patients who demonstrated cCR after receiving NAC with a combination of anthracycline and taxane from May 1998 to August 2003. Surgical treatment included breast‐conserving therapy followed by radiotherapy or mastectomy. The identity of post‐NAC lesions as either a complete response (CR) or partial response (PR) were made by mammography, ultrasonography, and contrast‐enhanced computed tomography (CT). Among the 35 patients, 11 achieved pCR, including the disappearance of both invasive and intraductal components. Of the patients achieving pCR, eight were defined as CR and three were determined to be PR by CT. There was a significant relationship between the pCR and the determination of CR by CT. The determination of CR by ultrasonography was indicative of the disappearance of pathologic invasive components. While mammography appeared to reflect the observed histologic results, we did not observe any statistical differences. A subset of cases exhibited discrepancies between the imaging and pathologic results, likely due to the replacement of destroyed tumor cells by fibrosis and granulomatous tissue. The evaluation of CR by CT was significantly indicative of pCR. The positive predictive value, however, was not large enough to avoid surgical treatment. Further studies will be needed to establish a diagnosis of pCR.Keywords
This publication has 11 references indexed in Scilit:
- The Use of Contrast-Enhanced Computed Tomography Before Neoadjuvant Chemotherapy to Identify Patients Likely to Be Treated Safely With Breast-Conserving SurgeryAnnals of Surgery, 2004
- Is Surgery Necessary After Complete Clinical Remission Following Neoadjuvant Chemotherapy for Early Breast Cancer?Journal of Clinical Oncology, 2003
- Accuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant ChemotherapyAmerican Journal of Roentgenology, 2003
- Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRIBreast Cancer Research and Treatment, 2003
- MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast CancerAnnals of Surgical Oncology, 2001
- Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapyInternational Journal of Cancer, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancerBreast Cancer Research and Treatment, 1998
- Breast surgery after neoadjuvant treatment. Is it necessary?European Journal of Surgical Oncology, 1996